Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castrate-resistant Prostate Cancer”

1,106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,106 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableTemporarily pausedNCT03236688
What this trial is testing

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Exosome Diagnostics, Inc. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02893917
What this trial is testing

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma With Neuroendocrine DifferentiationCastration-Resistant Prostate CarcinomaMetastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623460
What this trial is testing

Zanzalintinib Efficacy Post Pluvicto® in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Stuthi Perimbeti 30
Not applicableLooking for participantsNCT06321679
What this trial is testing

Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the Bone

Who this might be right for
Castration-resistant Prostate Cancer
European Institute of Oncology 40
Testing effectiveness (Phase 2)Ended earlyNCT00176631
What this trial is testing

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)Study completedNCT01650194
What this trial is testing

Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06844383
What this trial is testing

Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Not applicableWithdrawnNCT04742972
What this trial is testing

Prostate PMSABR Study

Who this might be right for
Prostate Cancer
Darren Poon
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Ended earlyNCT05553639
What this trial is testing

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Hookipa Biotech GmbH 12
Early research (Phase 1)Study completedNCT02826772
What this trial is testing

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Suzhou Kintor Pharmaceutical Inc, 40
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Not applicableStudy completedNCT01516866
What this trial is testing

Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 58
Early research (Phase 1)Looking for participantsNCT07244341
What this trial is testing

Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 60
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Early research (Phase 1)Active Not RecruitingNCT03873805
What this trial is testing

PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+2 more
City of Hope Medical Center 14
Load More Results
90